Misspecified regression model for the subdistribution hazard of a competing risk

Statistics in Medicine

Volumn 26, Issue 5, 2007, Pages 965-974

  Latouche, Aurelien ^a   Boisson, V ^b   Chevret, S ^a   Porcher, R ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Cause specific; Cumulative incidence; Model misspecification; Proportional hazards

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CHROMOSOME ANALYSIS; CLINICAL RESEARCH; DISEASE FREE INTERVAL; HUMAN; KARYOTYPE; OUTCOME ASSESSMENT; PARAMETRIC TEST; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ACUTE DISEASE; DATA INTERPRETATION, STATISTICAL; FRANCE; HUMANS; LEUKEMIA; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 33847094543     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2600     Document Type: Article

References (17)

1. Andersen PK, Abildstrøm SZ, Rosthøj S. Competing risks as a multi-state model. Statistical Methods in Medical Research 2002; 11:203-215.
2. Prentice RL, Kalbfleisch JD, Peterson AV, FIournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34:541-554.
3. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 1988; 116:1141-1154.
4. Pepe MS. Inference for events with dependent risks in multiple endpoint studies. Journal of the American Statistical Association 1991; 86:770-778.
5. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics 2005; 61(1):223-229.
6. Fine JP, Gray RJ. A proportional hazards model for subdislribution of a competing risk. Journal of the American Statistical Association 1999; 94(446):496-509.
7. Fine JP. Regression modelling of competing crude failure probabilities. Biostatistics 2001; 2:85-97.
8. Tsiatis AA. A nonidentifiability aspect of the problem of competing risks. Proceedings of the National Academy of Sciences 1975; 72(1):20-22.
9. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine 1993; 12:737-751.
10. Freidlin B, Korn EL. Testing treatment effects in the presence of competing risks. Statistics in Medicine 2005; 24(11): 1703-1712.
11. Castaigne S, Chevret S, Archimbaud E, Fenaux P, Bordessoule D, Tilly H, de Revel T, Simon M, Dupriez B, Renoux M, Janvier M, Miclea JM, Thomas X, Bastard C, Preudhomme C, Bauters F, Degos L, Dombret H. Randomized comparison of double induction and timed-sequential induction to a '3 + 7' induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study. Blood 2004; 104(8):2467-2474.
12. Solomon PJ. Effect of misspecification of regression models in the analysis of survival data. Biometrika 1984: 71(2):291-298.
13. Struthers CA, Kalbfleisch JD. Misspecified proportional hazard models. Biometrika 1986; 73(2):363-369.
14. Block HW, Basu AP. A continuous bivariate exponential extension. Journal of the American Statistical Association 1974; 69(348):1031-1037.
15. Friday D, Patil G. A bivariate exponential model with applications to reliability and computer generation of random variables. In The Theory and Applications of Reliability, Tsokos C, Shimi I (eds). Academic Press: New York, 1977; 527-549.
16. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2005. ISBN 3-900051-07-0.
17. Klein JP. Modelling competing risks in cancer studies. Statistics in Medicine 2006; 25(6):1015-1034.